Blog

Mesoblast and Cartherics form partnership to develop ‘off-the-shelf’ CAR-T therapies for solid cancers – News-Medical.net


News-Medical.net

Mesoblast and Cartherics form partnership to develop 'off-the-shelf' CART therapies for solid cancers
News-Medical.net
Relapsed Ovarian and Gastric Cancers Initial Targets for Allogeneic CART Cells. Mesoblast Limited today announced that it has entered into a partnership with Cartherics Pty Ltd to develop allogeneic 'off-the-shelf' CART cells armed with multiple

2018-05-31 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.